Immunofluorescence

Cytological application

Reveal the essence of CTCs through immunofluorescence

Immunofluorescence on circulating tumor cells (CTCs) is an essential technique in oncology because it allows the multiplexed analysis of several cellular markers simultaneously. This ability to detect several specific biomarkers in a single preparation offers a detailed and comprehensive view of CTCs, thus facilitating the study of their heterogeneity and the evaluation of their role in tumor evolution.

Immunofluorescence MCF-7 K 17 19 CD45 DAPI

Immunofluorescence on CTCs is a crucial tool to explore the molecular characteristics of circulating tumor cells. It provides detailed information on the surface profiles of CTCs, facilitating the identification of specific tumor cells in the blood.

ScreenCell kits for
immunofluorescence

CYTO

Blood sample < 4 hours

Cells fixed and analyzed on the isolation support

CSB

Blood sample < 3 days

Cells fixed and analyzed on the isolation support

FCD

Blood sample < 3 days

or

Fixed cells detached
from the isolation support for analysis in suspension or on slide

FCD-SP

Blood sample < 4 hours

or

Fixed cells detached
from the isolation support for analysis in suspension or on slide

Remarkable results

ScreenCell kits, compatible with immunofluorescence on CTCs, guarantee high quality results thanks to precise detection of biological markers and a high recovery rate, thanks to our optimized protocols.

Some of our references
in immunofluorescence

Rapid separation of mononuclear hodgkin from multinuclear reed-sternberg cells

Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival

Perioperative detection of circulating tumour cells in patients with lung cancer.

Blog

What Are Circulating Tumor Cells ?

Just like our footprints in the snow, cancer leaves a mark as it seeks to spread to other organs. These...

Tell us about your project

Are you interested in establishing a fundamental or clinical research project focused on circulating tumor cells (CTCs) or liquid biopsy ?

Share your project details with us, and we will be delighted to assist you in bringing it to fruition.

Liquid biopsy for
enhancing patient care
through reliable CTC analysis

Webinar

Circulating Tumor Cell Analysis :
a new workflow combining ScreenCell® Technology
with Stilla Crystal Digital PCR®

Tuesday, April 8, 2025
04:00 PM CET
Wednesday, April 9, 2025
03:00 PM CST